<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Bariatric surgery for management of obesity: Indications and preoperative preparation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Bariatric surgery for management of obesity: Indications and preoperative preparation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Bariatric surgery for management of obesity: Indications and preoperative preparation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert B Lim, MD, FACS, FASMBS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel Jones, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 04, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obesity, defined as a body mass index (BMI) ≥30 kg/m
         <sup>
          2
         </sup>
         , is a chronic illness identified in children, adolescents, and adults worldwide [
         <a href="#rid1">
          1,2
         </a>
         ]. According to the World Health Organization, worldwide there are approximately 650 million adults with obesity and 42 million children with obesity under the age of five years [
         <a href="#rid3">
          3
         </a>
         ]. In the United States, 35 percent of adults (roughly 100 million people) and 17 percent of children have obesity [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         The surgical procedures performed to manage obesity are collectively referred to as metabolic or "bariatric" surgery (from the Greek words "baros," meaning "weight," and "iatrikos," meaning "medicine"). This topic will discuss the indications and contraindications for a bariatric surgical procedure as well as the optimal preoperative preparation in a multidisciplinary setting. A description of the types of bariatric procedures, as well as the complications and outcomes, is found in separate topics.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/585.html" rel="external">
          "Bariatric operations: Late complications with subacute presentations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Screening, the general medical approach to the management of obesity, and clinical practice guidelines from the American College of Physicians for management of obesity in primary care settings are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5372.html" rel="external">
          "Obesity in adults: Prevalence, screening, and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5371.html" rel="external">
          "Obesity in adults: Overview of management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2963728">
         <span class="h1">
          BACKGROUND
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are several well-established health hazards linked to obesity, including type 2 diabetes mellitus, heart disease, stroke, cancers (eg, breast, colon, uterine), osteoarthritis, liver disease, obstructive sleep apnea, and depression  (
         <a class="graphic graphic_table graphicRef69532" href="/z/d/graphic/69532.html" rel="external">
          table 1
         </a>
         ). The risk of developing complications rises with increasing adiposity, while weight loss can reduce the risk or improve medical conditions, such as for hypertension and diabetes. (See
         <a class="medical medical_review" href="/z/d/html/5370.html" rel="external">
          "Overweight and obesity in adults: Health consequences"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1529.html" rel="external">
          "Obesity: Association with cardiovascular disease", section on 'Benefits of weight loss'
         </a>
         .)
        </p>
        <p>
         In addition to the impact on health, the economic costs of obesity are staggering [
         <a href="#rid5">
          5-7
         </a>
         ]. The cost of treating obesity and its complications in the United States (US) is over 200 billion US dollars per year and over 20 percent of the US's entire health expenditure [
         <a href="#rid6">
          6,8
         </a>
         ]. Additionally, obesity and its complications lead to other significant costs, such as missed days of work and decreased life expectancy [
         <a href="#rid5">
          5
         </a>
         ]. Similar trends have been reported in other parts of the world [
         <a href="#rid9">
          9,10
         </a>
         ].
        </p>
        <p>
         Medical and behavioral approaches to weight loss may be ineffective for many individuals with obesity. The best method for obtaining and sustaining significant weight loss for such patients and treating comorbidities such as hypertension, hyperlipidemia, sleep apnea, and type 2 diabetes mellitus is obesity surgery. Patients who undergo bariatric surgery have lower long-term mortality rates compared with matched controls who did not have bariatric surgery [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery"
         </a>
         .)
        </p>
        <p>
         Hence, bariatric surgical procedures are increasingly common worldwide. The International Federation for the Surgery of Obesity and Metabolic Diseases estimates that there were about 394,431 bariatric procedures performed worldwide in 2018 [
         <a href="#rid12">
          12
         </a>
         ]. Countries where &gt;10,000 bariatric procedures were performed in 2014 include [
         <a href="#rid13">
          13,14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         US and Canada (n = 256,000 in 2019 [
         <a href="#rid15">
          15
         </a>
         ])
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brazil (n = 65,000)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         France (n = 27,648)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mexico (n = 19,000)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Australia and New Zealand (n = 12,000)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         United Kingdom (n = 10,000)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2963932">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Indications for the surgical management of severe obesity were first outlined by the National Institutes of Health (NIH) Consensus Development Panel in 1991 [
         <a href="#rid16">
          16
         </a>
         ]. In 2017, an international consensus conference, the second Diabetes Surgery Summit (DSS-II), called for expanding access to bariatric surgery to individuals of lower body mass index, different ethnic groups, and those with inadequate control of hyperglycemia [
         <a href="#rid17">
          17
         </a>
         ]. These broader inclusion criteria have since been endorsed by 45 international medical and scientific organizations. In 2022, the American Society of Metabolic and Bariatric Surgery (ASMBS) and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) published updated indications for bariatric surgery [
         <a href="#rid18">
          18
         </a>
         ]. Candidates for a bariatric surgical procedure include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults with a body mass index (BMI) ≥35 kg/m
         <sup>
          2
         </sup>
         regardless of the presence, absence, or severity of comorbidities. Bariatric surgery has been proven superior to diet, exercise, and other lifestyle interventions in attaining substantial and durable weight loss and improving obesity-related comorbid conditions in class II or greater obesity [
         <a href="#rid19">
          19-29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults with a BMI between 30.0 and 34.9 kg/m
         <sup>
          2
         </sup>
         and type 2 diabetes. Bariatric surgery is now considered to be a treatment option for diabetes in patients with class I obesity who do not achieve substantial or durable weight loss or comorbidity improvement with nonsurgical methods. Large retrospective and prospective studies that either included or exclusively enrolled patients with class I obesity have demonstrated superior and durable weight loss and diabetes control with bariatric surgery [
         <a href="#rid17">
          17,30-48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1790.html" rel="external">
          "Management of persistent hyperglycemia in type 2 diabetes mellitus", section on 'Bariatric (metabolic) surgery'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery", section on 'Diabetes mellitus'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults with a BMI between 30.0 and 34.9 kg/m
         <sup>
          2
         </sup>
         who cannot achieve substantial or sustainable weight loss or comorbidity improvement with nonsurgical weight loss methods. Ample data consistently demonstrate the weight loss and metabolic benefits of bariatric surgery in individuals with class I obesity [
         <a href="#rid49">
          49
         </a>
         ]. The comorbid conditions that are often tied to obesity and can be improved by weight loss include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Type 2 diabetes [
         <a href="#rid17">
          17,48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Obstructive sleep apnea (OSA).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypertension.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hyperlipidemia.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Obesity-hypoventilation syndrome (OHS).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pickwickian syndrome (combination of OSA and OHS).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nonalcoholic fatty liver disease (NAFLD).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nonalcoholic steatohepatitis (NASH).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pseudotumor cerebri.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gastroesophageal reflux disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Asthma.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Venous stasis disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe urinary incontinence.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Debilitating arthritis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Impaired quality of life.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Disqualification from other surgeries due to obesity (ie, surgeries for osteoarthritic disease, ventral hernias, or stress incontinence).
        </p>
        <p>
        </p>
        <p>
         Consideration should be given for race. There is growing evidence that the prevalence of diabetes and cardiovascular disease is higher at a lower BMI in the Asian than in the non-Asian population due to a higher prevalence of truncal obesity (ie, visceral fat), which is felt to be more hazardous than peripherally located fat [
         <a href="#rid50">
          50
         </a>
         ]. Thus, BMI criteria can be lowered by 2.5 kg/m
         <sup>
          2
         </sup>
         per class, and those with BMI ≥27.5 kg/m
         <sup>
          2
         </sup>
         can be offered bariatric surgery rather than 30 kg/m
         <sup>
          2
         </sup>
         as above.
        </p>
        <p>
         It should be noted that many bariatric surgery programs encourage (or require) patients to participate in lifestyle changes prior to surgery to demonstrate their commitment, but any resultant weight loss could decrease the patient's BMI to the extent that the patient no longer meets the criteria at the time the surgery is finally scheduled, even though they met criteria upon entry into the bariatric surgery program. The overwhelming majority of bariatric surgeons feel that such a reduction in BMI should not prevent the patient from having surgery and will typically use the initial entry BMI.
        </p>
        <p>
         The ASMBS recognizes obesity as a chronic disease, and any weight lost in preparation for surgery is not likely to be substantial enough to treat comorbidities, and also not likely to be sustained [
         <a href="#rid51">
          51
         </a>
         ]. As such, this preoperative weight loss should not preclude surgery [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="local">
          'Preoperative weight loss'
         </a>
         below.)
        </p>
        <p>
         The policy of the individual surgeon should be discussed with the patient relative to the accepted indications for bariatric surgery. Not proceeding with surgery is an option if the patient feels they may be able to continue to lose weight and sustain their weight loss without surgery. Insurance coverage is very variable by carrier and policy, and substantial preoperative weight loss can adversely change insurance coverage benefits for weight loss surgery.
        </p>
        <p class="headingAnchor" id="H2965578">
         <span class="h1">
          CONTRAINDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bariatric procedures should not be performed for glycemic or lipid control or for cardiovascular risk reduction independent of the body mass index (BMI) parameters [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
         Other medical or psychiatric conditions that preclude a bariatric surgical procedure include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Untreated major depression or psychosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Uncontrolled and untreated eating disorders (eg, bulimia [
         <a href="#rid53">
          53
         </a>
         ])
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Current drug and alcohol abuse
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe cardiac disease with prohibitive anesthetic risks
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe coagulopathy
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inability to comply with nutritional requirements including lifelong vitamin replacement
        </p>
        <p>
        </p>
        <p>
         There is no upper patient age limit to bariatric surgery. Instead, fragility is a better predictor of outcome than age alone [
         <a href="#rid54">
          54,55
         </a>
         ]. Bariatric surgery for patients younger than 18 years is becoming more common and is endorsed for use by the American Academy of Pediatrics for patients with severe obesity under the recommendation that only high-quality programs that provide both pediatric and transition to adult care be allowed to perform it in this population [
         <a href="#rid56">
          56,57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5880.html" rel="external">
          "Surgical management of severe obesity in adolescents"
         </a>
         .)
        </p>
        <p>
         Additionally, bariatric surgery is an effective treatment for clinically severe obesity in patients who need other specialty surgery, such as joint arthroplasty, abdominal wall hernia repair, or organ transplantation [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2967550">
         <span class="h1">
          PREOPERATIVE ASSESSMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bariatric surgery should be performed in conjunction with a comprehensive preoperative assessment and a follow-up plan consisting of medical, nutritional, and behavioral programs.
        </p>
        <p>
         A multidisciplinary team that includes a primary care provider, nutritionist, medical bariatric specialist, psychologist/psychiatrist, nurse specialist, and skilled surgeon offers well-rounded assessments and support for those considering a bariatric surgical procedure. The advantage of the team approach is assistance provided to the patient that facilitates the long-term lifestyle changes conducive to long-term maintenance of weight loss.
        </p>
        <p class="headingAnchor" id="H2967557">
         <span class="h2">
          Psychosocial assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients seeking bariatric surgery should be assessed by a qualified behavioral health clinician for psychosocial functioning, substance abuse, or maladaptive eating behaviors [
         <a href="#rid58">
          58
         </a>
         ]. Any psychopathology, substance abuse, or eating disorder uncovered should receive adequate referral and treatment. All patients should also be educated about new psychosocial problems that could emerge after bariatric surgery.
        </p>
        <p>
         Individuals with obesity, especially those seeking bariatric surgery, have a higher prevalence of mental health impairments than the general population [
         <a href="#rid59">
          59
         </a>
         ]. The goal of presurgical psychologic testing is to identify any previously undiagnosed psychiatric disorders and determine if an operative candidate is able and willing to make the necessary lifestyle changes required for sustainable weight loss. Any significant psychiatric disorders (eg, bipolar disorder, major depression, antisocial personality disorder) can then be treated preoperatively to minimize challenges to weight loss initiatives and reduce risk for postoperative psychiatric complications [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
         Untreated major depression or psychosis, uncontrolled and untreated eating disorders (eg, bulimia), and active drug or alcohol abuse are contraindications to bariatric surgery. (See
         <a class="local">
          'Contraindications'
         </a>
         above.)
        </p>
        <p>
         After bariatric surgery, new psychosocial issues may arise ranging from problems with interpersonal relationships, body image, or day-to-day functioning to severe, even life-threatening psychopathologies (eg, self-harm, suicide). (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery", section on 'Psychosocial impact'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1094894136">
         <span class="h2">
          Nutritional assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients seeking bariatric surgery should be evaluated by a registered dietitian for the following [
         <a href="#rid61">
          61
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Weight history and eating behaviors
         </strong>
         – Patterns of previous weight loss and regain provide information about eating habits and lifestyle that may be relevant to the management of the short-term and long-term postoperative course. The lack of previous weight loss attempts should not preclude consideration for bariatric surgery [
         <a href="#rid62">
          62-64
         </a>
         ]. Eating and dietary style queries should include for binge eating, grazing, overeating, nighttime eating, and stress-related eating patterns, which may identify maladaptive eating styles.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Medication review
         </strong>
         – Medications that can be potentially associated with weight gain or increased appetite include antihypertensives, diabetes medications, hormone therapies, antiseizure medications, antidepressants, mood stabilizers, antipsychotics, migraine medications, and anti-inflammatory agents [
         <a href="#rid58">
          58
         </a>
         ]. If possible, a substitution should be made in consultation with the prescriber.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Body composition and energy requirement analysis
         </strong>
         – If available, a baseline measurement of the patient's body composition and energy requirement should be made [
         <a href="#rid65">
          65
         </a>
         ]. Repeat measurements after surgery will help prescribe caloric requirements and ensure long-term weight loss.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Micronutrient deficiency analysis
         </strong>
         – A nutrition-focused physical examination and specific bariatric micronutrient (thiamin; vitamins B12, A, E, D, and K; folate; iron studies; ferritin; and calcium) assessment should be performed. Most individuals seeking bariatric surgery have at least one micronutrient deficiency [
         <a href="#rid66">
          66
         </a>
         ]. Early diagnosis permits replacement therapy and improved monitoring postoperatively. (See
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management", section on 'Presurgical screening'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In addition, with the dietician's help, all patients should make nutritional plans for before, around the time of, and after bariatric surgery. Nutritional education should also provide information on how to read the nutritional content of foods, select appropriate portion sizes, find snack and beverage alternatives, prepare foods, and shop for one's loved ones (if applicable). Many programs will also provide meal preparation classes for their patients.
        </p>
        <p class="headingAnchor" id="H2967619">
         <span class="h2">
          Medical assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals seeking bariatric surgery should be evaluated by a medical bariatric specialist, their primary care provider, and additional specialists (eg, cardiologist, pulmonologist) to ensure that they can tolerate and are optimized for the proposed surgery.
        </p>
        <p class="headingAnchor" id="H4116387411">
         <span class="h3">
          History and physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         A complete history and physical examination is performed to assess for comorbid illnesses, such as hypertension, diabetes, obstructive sleep apnea (OSA), malnutrition, restrictive lung disease, and the individual's appropriateness as a surgical candidate. Many patients have undiagnosed ailments related to their obesity.
        </p>
        <p class="headingAnchor" id="H1180545514">
         <span class="h3">
          Laboratory studies
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with renal dysfunction due to longstanding hypertension or diabetes, we obtain serum chemistry tests that include blood urea nitrogen and creatinine.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients suspected to have nonalcoholic fatty liver disease (NAFLD) on the basis of hepatomegaly on the physical examination, liver function tests are obtained [
         <a href="#rid67">
          67
         </a>
         ]. The need for liver biopsy should be guided by preoperative clinical scores, liver stiffness measurement, and any signs of portal hypertension/chronic liver disease [
         <a href="#rid68">
          68
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3625.html" rel="external">
          "Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baseline glycated hemoglobin (A1C) and fasting glucose levels should be obtained in all patients seeking bariatric surgery [
         <a href="#rid58">
          58,69
         </a>
         ]. Patients with known or newly diagnosed type 2 diabetes or prediabetes should be treated before surgery, and early postoperative hyperglycemia should be avoided. In bariatric surgery, adverse outcomes have closer association with early postoperative glycemic control than with preoperative A1C value [
         <a href="#rid70">
          70,71
         </a>
         ]. Thus, bariatric surgery should not be delayed or withheld for a high preoperative high A1C value.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A fasting lipid panel should be obtained in all patients seeking bariatric surgery. Those diagnosed with dyslipidemia should be treated [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Testing for gout and subsequent treatment of gout in all patients seeking bariatric surgery are recommended. Given the high likelihood of gouty attacks postoperatively, prophylaxis may be warranted in those who have a history of gout. (See
         <a class="medical medical_review" href="/z/d/html/105886.html" rel="external">
          "Nonpharmacologic strategies for the prevention and treatment of gout"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We test for hypothyroidism in patients who have symptoms. We do not obtain thyroid-stimulating hormone (TSH) in asymptomatic patients, as TSH level can be elevated in euthyroid patients with obesity. (See
         <a class="medical medical_review" href="/z/d/html/7846.html" rel="external">
          "Clinical manifestations of hypothyroidism"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1897165805">
         <span class="h3">
          Further assessments
         </span>
         <span class="headingEndMark">
          —
         </span>
         Based upon the medical history, physical examination, and laboratory tests, the preoperative medical assessment may also involve other specialists in the following areas:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Obstructive sleep apnea
         </strong>
         – The prevalence of OSA in individuals with obesity ranges from 35 to 94 percent, with most studies reporting a rate &gt;60 percent [
         <a href="#rid73">
          73
         </a>
         ]. Thus, screening for OSA with one of the questionnaire-based methods such as STOP-Bang  (
         <a class="graphic graphic_table graphicRef87572" href="/z/d/graphic/87572.html" rel="external">
          table 2
         </a>
         ) is recommended for all patients seeking bariatric surgery. Confirmatory tests, such as polysomnography (ie, sleep study) or home polygraphy, should be offered to those who are at high risk of having OSA based upon the initial screen. Patients with diagnosed severe OSA and/or obesity-hypoventilation syndrome should be referred to a pulmonologist. Those with moderate-to-severe OSA may also benefit from positive continuous airway pressure (CPAP) therapy. (See
         <a class="medical medical_review" href="/z/d/html/13516.html" rel="external">
          "Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea", section on 'Screening with a questionnaire'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac assessment
         </strong>
         – There is no bariatric-surgery-specific protocol for preoperative cardiac assessment. Thus, we use the standard approach [
         <a href="#rid58">
          58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">
          "Evaluation of cardiac risk prior to noncardiac surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We screen all patients with a validated cardiac risk calculator (eg, the Revised Cardiac Risk Index), determine their functional capacity, and perform an electrocardiogram. We then refer low-risk patients to their primary care provider for cardiac clearance and high-risk patients and those with a moderate-to-severe preexisting cardiovascular disease (eg, recent myocardial infarction, unstable angina, uncompensated heart failure, high-grade arrhythmia, or hemodynamically significant valvular heart disease) to a cardiologist for further testing/evaluation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         It should be noted that bariatric surgery has strong cardiovascular benefits and a very low risk profile and therefore should be considered even in patients with significant cardiac disease and/or risk [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery", section on 'Cardiovascular risk'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gastrointestinal assessment
         </strong>
         – Depending on the bariatric procedure planned and symptoms (eg, reflux, dysphagia), some patients may benefit from additional assessment of the upper digestive system, including possible upper gastrointestinal series, upper endoscopy, esophageal pH study, or manometry. This is discussed in topics on individual bariatric procedures. (See
         <a class="medical medical_review" href="/z/d/html/109435.html" rel="external">
          "Laparoscopic sleeve gastrectomy", section on 'Preoperative workup'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/109434.html" rel="external">
          "Laparoscopic Roux-en-Y gastric bypass", section on 'Preoperative workup'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cancer screening
         </strong>
         – Obesity increases the prevalence of a number of malignancies. As such, patients seeking bariatric surgery should be encouraged to undergo age-appropriate cancer screening such as colonoscopy and mammography [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2967626">
         <span class="h2">
          Anesthetic risk assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obesity leads to respiratory and cardiovascular changes that impact the delivery of general anesthesia along with perioperative analgesia. The physiologic and anatomic changes associated with obesity and the management of anesthetics and analgesics are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/14932.html" rel="external">
          "Anesthesia for the patient with obesity"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13516.html" rel="external">
          "Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2896145449">
         <span class="h1">
          PREOPERATIVE INTERVENTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following interventions are strongly encouraged in all individuals seeking bariatric surgery. Some have been shown to improve outcomes after bariatric surgery; for the others, the benefit is inferred from similar nonbariatric surgeries.
        </p>
        <p class="headingAnchor" id="H2087029081">
         <span class="h2">
          Smoking cessation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tobacco smoking within one year prior of bariatric surgery is known to increase 30 day mortality and major postoperative complications [
         <a href="#rid76">
          76,77
         </a>
         ]. Smoking cessation programs initiated four to eight weeks before general and orthopedic surgery have reduced complication rates [
         <a href="#rid78">
          78
         </a>
         ]. Thus, patients seeking bariatric surgery who smoke tobacco or marijuana should be encouraged to stop smoking at least six weeks before bariatric surgery.
        </p>
        <p>
         Patients should be referred to their primary care provider or a dedicated smoking cessation program.
         <a class="drug drug_general" data-topicid="9698" href="/z/d/drug information/9698.html" rel="external">
          Nicotine
         </a>
         replacement therapy is safe and efficacious for use in preoperative smoking cessation programs, while other agents are less well studied.
        </p>
        <p>
         In a prospective cohort study of 1770 patients who underwent Roux-en-Y gastric bypass, 45 percent reported a history of smoking [
         <a href="#rid79">
          79
         </a>
         ]. Modeled prevalence of current smoking decreased in the year before surgery from 13.7 to 2.2 percent at surgery but increased to 9.6 percent one year post-surgery and continued to increase to 14.0 percent seven years post-surgery. In another study, 65 percent of recent smokers resumed smoking after bariatric surgery, with about half experiencing a marginal ulcer after Roux-en-Y gastric bypass [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p>
         Though it is not clear what impact smoking relapse has after sleeve gastrectomy, it is recommended that tobacco cessation therapy be continued after all bariatric surgery. (See
         <a class="medical medical_review" href="/z/d/html/16635.html" rel="external">
          "Pharmacotherapy for smoking cessation in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1194650399">
         <span class="h2">
          Alcohol cessation
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, it is recommended that all alcohol use should be stopped before bariatric surgery, but the exact timing for this is unknown. In patients with a known alcohol abuse diagnosis, alcohol drinking should be stopped for at least one year before surgery [
         <a href="#rid81">
          81
         </a>
         ]. Alcohol use or a history of alcohol abuse, though, are not contraindications to bariatric surgery [
         <a href="#rid82">
          82
         </a>
         ]. Certainly, patients with known liver disease, whether or not it is related to alcohol, have a higher risk of postoperative complications [
         <a href="#rid83">
          83
         </a>
         ]. Postoperatively there is a significant incidence of alcohol abuse after bariatric surgery, and thus each patient must be informed about this and monitored for this [
         <a href="#rid84">
          84
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery", section on 'Alcohol and other substance abuses'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4256532813">
         <span class="h2">
          Estrogen cessation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Estrogen-containing oral contraceptives and hormone-replacement therapy increase venous thromboembolic (VTE) risk, which compounds the VTE risk of obesity [
         <a href="#rid85">
          85,86
         </a>
         ]. With regards to bariatric surgery, the information is less robust, but it is generally recommended to avoid estrogen-containing forms of contraception prior and post-surgery [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Women should stop taking estrogen-containing oral contraceptives for one month before bariatric surgery [
         <a href="#rid88">
          88
         </a>
         ]. They should consult with their gynecologist to seek safe alternatives such as progestin-only oral contraceptives or an intrauterine device. (See
         <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">
          "Combined estrogen-progestin contraception: Side effects and health concerns", section on 'Venous thromboembolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Furthermore, they should be told that pregnancy is discouraged within the first 18 to 24 months after surgery. Although patients are not required to be on birth control during that period of time, they should be given the opportunity to discuss their options. Estrogen-containing contraceptives should be avoided in the perioperative period for at least one month due to the continued risk of VTE. Women interested in contraception should also discuss the bioavailability of their birth control pill with their gynecologist; patients undergoing a malabsorptive procedure may not adequately absorb certain birth control pills to prevent pregnancy. (See
         <a class="medical medical_review" href="/z/d/html/411.html" rel="external">
          "Fertility and pregnancy after bariatric surgery", section on 'Contraception'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Women should stop taking hormone replacement therapy for three weeks before bariatric surgery [
         <a href="#rid88">
          88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7427.html" rel="external">
          "Menopausal hormone therapy: Benefits and risks", section on 'Venous thromboembolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         For all patients with hypercoagulable states or a history of a VTE event, consultation with hematology/oncology should be obtained to determine the type and duration of perioperative thromboprophylaxis. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients", section on 'Selecting thromboprophylaxis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4282963951">
         <span class="h2">
          Preoperative weight loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is evidence that a low- (800 to 1200 kcal) or very-low- (400 to 800 kcal) calorie diet for 2 to 12 weeks may induce sufficient weight loss to improve the technical ease of bariatric surgery by reducing the volume of the liver (by 15 to 30 percent) and overall adiposity [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         However, inability to adhere to such a strict diet or lose weight should not preclude bariatric surgery, and such dieting should not be confused with insurance-mandated preoperative diets. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H658036012">
         <span class="h2">
          Prehabilitation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prehabilitation programs are 4 to 12 weeks of supervised physical exercise, aggressive diabetes control, alcohol and tobacco cessation, and pulmonary interventions typically given as a part of Enhanced Recovery After Surgery (ERAS) programs. While there is general success with the use of ERAS protocols, the extent to which prehabilitation helps is unknown. With major abdominal surgery, prehabilitation has been shown to improve patient outcomes such as reduced overall and pulmonary complications and shorter length of stay; data are more limited in bariatric surgery [
         <a href="#rid89">
          89
         </a>
         ]. It is not known whether prehabilitation is required or can benefit laparoscopic bariatric surgery or a subset of individuals such as those with class 3 obesity. (See
         <a class="medical medical_review" href="/z/d/html/120301.html" rel="external">
          "Overview of prehabilitation for surgical patients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3933452593">
         <span class="h1">
          PREOPERATIVE COUNSELING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bariatric surgical candidates should have the intellectual resources to understand the type of procedure to be performed, the risks of the procedure, and the behavioral changes that are key to effective weight loss. Deficits can be addressed, such as training the patient to develop coping skills, counseling to eliminate maladaptive behavior, and taking the time to educate the patient not only on the risks and benefits of the surgery but also the risks of obesity [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
         Psychosocial, emotional, and lifestyle expectations should be assessed to determine if they are realistic and if the patient is committed to actively and permanently following postoperative guidelines for improved health. Many patients with obesity may have preconceived ideas about the benefits of bariatric operations and lack a realistic expectation of the lifestyle changes that are mandatory to achieve weight loss goals. Preoperative counseling should reinforce goals and the means to achieve them.
        </p>
        <p>
         The
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Friskcalculator.facs.org%2Fbariatric%2F&amp;token=6gVWib8LYMmb6itGH0wlY%2Ff2oHJ5SEnQyuGi9bDrAXHJYguUbt9jYFHE2ay0fRWAavcK%2BnOZQNpBBpz7VPCyOw%3D%3D&amp;TOPIC_ID=586" target="_blank">
          Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) bariatric surgical risk/benefit calculator
         </a>
         estimates the chance of an unfavorable outcome (such as a complication or death), the chance of remission of weight-related comorbidities, and the patient's body mass index (BMI), weight change, and percent total weight change after surgery. These outcomes are calculated using the patient's preoperative information as well as data from a large number of other patients who had a similar bariatric surgical procedure.
        </p>
        <p>
         Overall, the 30 day risk models were accurate and well calibrated, with acceptable discrimination [
         <a href="#rid90">
          90
         </a>
         ]. The
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Friskcalculator.facs.org%2Fbariatric%2F&amp;token=6gVWib8LYMmb6itGH0wlY%2Ff2oHJ5SEnQyuGi9bDrAXHJYguUbt9jYFHE2ay0fRWAavcK%2BnOZQNpBBpz7VPCyOw%3D%3D&amp;TOPIC_ID=586" target="_blank">
          MBSAQIP bariatric surgical risk/benefit calculator
         </a>
         is publicly available, with the intent to be integrated into health care practice to guide bariatric surgical decision making and care planning and enhance communication between patients and their surgical care team.
        </p>
        <p class="headingAnchor" id="H2515253482">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112687.html" rel="external">
          "Society guideline links: Bariatric surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16640.html" rel="external">
          "Patient education: Weight loss surgery (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/1988.html" rel="external">
          "Patient education: Losing weight (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/1987.html" rel="external">
          "Patient education: Weight loss surgery and procedures (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Background
         </strong>
         – Obesity is a worldwide chronic condition that affects children, adolescents, and adults with huge health and economic impacts. As medical and behavioral approaches to weight loss may be ineffective for many individuals with obesity, bariatric surgical procedures are increasingly common worldwide. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Background'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – Appropriate candidates for bariatric surgery include (see
         <a class="local">
          'Indications'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adults with a body mass index (BMI) ≥35 kg/m
         <sup>
          2
         </sup>
         regardless of the presence, absence, or severity of comorbidities.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adults with a BMI between 30.0 and 34.9 kg/m
         <sup>
          2
         </sup>
         and type 2 diabetes.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adults with a BMI between 30.0 and 34.9 kg/m
         <sup>
          2
         </sup>
         who cannot achieve substantial or sustainable weight loss or comorbidity improvement with nonsurgical weight loss methods.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For Asian patients, the BMI criteria can be lowered by 2.5 kg/m
         <sup>
          2
         </sup>
         per class, related to a higher prevalence of truncal obesity (ie, visceral fat).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contraindications
         </strong>
         – Bariatric procedures are not performed for (see
         <a class="local">
          'Contraindications'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Glycemic or lipid control or cardiovascular risk reduction independent of the BMI parameters.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Untreated or uncontrolled psychosocial disorders (eg, major depression, psychosis, bulimia, substance abuse).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inability to tolerate surgery (eg, severe cardiopulmonary disease, coagulopathy).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inability to comply with postoperative nutritional requirements (eg, vitamin supplementation).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative assessments
         </strong>
         – Patients seeking bariatric surgery should be assessed by (see
         <a class="local">
          'Preoperative assessment'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A qualified behavioral health clinician for psychosocial functioning, substance abuse, or maladaptive eating behaviors.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A registered dietitian for weight history and eating behavior, medication review, body composition and energy expenditure, and micronutrient deficiency.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The bariatrician, primary care provider, or other specialists for obstructive sleep apnea (OSA), diabetes, heart disease, dyslipidemia, gout, and hypothyroidism, among other comorbid conditions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative interventions
         </strong>
         – Patients seeking bariatric surgery should be encouraged to (see
         <a class="local">
          'Preoperative interventions'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Stop smoking tobacco or marijuana at least six weeks before surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Avoid alcohol use for at least one year if there is a history of alcohol abuse. Stop alcohol use for at least one month prior to surgery, and counsel patients on the risk of developing alcohol abuse postoperatively.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For all individuals seeking bariatric surgery, we suggest stopping estrogen-containing oral contraceptives one month or hormone replacement therapy three weeks before surgery to reduce the risk of venous thromboembolism (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Participate in a preoperative weight loss program with a low-caloric diet for 2 to 12 weeks before surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Participate in a physical exercise and pulmonary intervention (prehabilitation) program for 4 to 12 weeks before surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative counseling
         </strong>
         – Patients seeking bariatric surgery should be counselled to develop coping skills, eliminate maladaptive behavior, and understand the risks and benefits of the surgery. Online resources such as the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Friskcalculator.facs.org%2Fbariatric%2F&amp;token=6gVWib8LYMmb6itGH0wlY%2Ff2oHJ5SEnQyuGi9bDrAXHJYguUbt9jYFHE2ay0fRWAavcK%2BnOZQNpBBpz7VPCyOw%3D%3D&amp;TOPIC_ID=586" target="_blank">
          Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) calculator
         </a>
         may help patients set realistic expectations about the outcomes of their bariatric surgery. (See
         <a class="local">
          'Preoperative counseling'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2:51S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. Fact sheet: Obesity and overweight. Available at: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight (Accessed on March 12, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludwig DS, Pollack HA. Obesity and the economy: from crisis to opportunity. JAMA 2009; 301:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frezza EE, Wachtel MS, Ewing BT. The impact of morbid obesity on the state economy: an initial evaluation. Surg Obes Relat Dis 2006; 2:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ 2012; 31:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vlad I. Obesity costs UK economy 2bn pounds sterling a year. BMJ 2003; 327:1308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh RB, Pella D, Mechirova V, et al. Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group. Acta Cardiol 2007; 62:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA 2015; 313:62.
          </a>
         </li>
         <li class="breakAll">
          The International Federation for the Surgery of Obesity and Metabolic Disorders. 4th IFSO Global Registry Report. 2018. Available at: https://www.ifso.com/pdf/4th-ifso-global-registry-report-last-2018.pdf (Accessed on March 12, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angrisani L, Santonicola A, Iovino P, et al. Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014. Obes Surg 2017; 27:2279.
          </a>
         </li>
         <li class="breakAll">
          American Society for Metabolic and Bariatric Surgery (ASMBS). Estimate of bariatric surgery numbers, 2011-2018. Published June 2018. Available at: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers (Accessed on April 15, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991; 115:956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brito JP, Montori VM, Davis AM. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. JAMA 2017; 317:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis 2022; 18:1345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 2011; 253:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchwald H, Rudser KD, Williams SE, et al. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias. Ann Surg 2010; 251:1034.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev 2011; 12:602.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garb J, Welch G, Zagarins S, et al. Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass. Obes Surg 2009; 19:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valezi AC, Mali Junior J, de Menezes MA, et al. Weight loss outcome after silastic ring Roux-en-Y gastric bypass: 8 years of follow-up. Obes Surg 2010; 20:1491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toouli J, Kow L, Ramos AC, et al. International multicenter study of safety and effectiveness of Swedish Adjustable Gastric Band in 1-, 3-, and 5-year follow-up cohorts. Surg Obes Relat Dis 2009; 5:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010; 163:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366:1567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofsø D, Jenssen T, Bollerslev J, et al. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2011; 164:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006; 144:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sultan S, Parikh M, Youn H, et al. Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2. Surg Endosc 2009; 23:1569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parikh M, Duncombe J, Fielding GA. Laparoscopic adjustable gastric banding for patients with body mass index of &lt;or=35 kg/m2. Surg Obes Relat Dis 2006; 2:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011; 146:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI&gt;35 and &lt;35 kg/m2. J Gastrointest Surg 2008; 12:945.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35:1420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi J, Digiorgi M, Milone L, et al. Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. Surg Obes Relat Dis 2010; 6:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI &lt;35 kg/m2: an integrative review of early studies. Obes Surg 2010; 20:776.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index &lt;35 kg/m2. Obes Surg 2011; 21:889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 2010; 252:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 2010; 147:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 2009; 19:1077.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramos AC, Galvão Neto MP, de Souza YM, et al. Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI&lt;30 kg/m2 (LBMI). Obes Surg 2009; 19:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index &lt; 35 kg/m2. Diabetes Obes Metab 2012; 14:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang CK, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg 2011; 21:1344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index &lt;35 kg/m(2). Surg Obes Relat Dis 2010; 6:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wee CC, Pratt JS, Fanelli R, et al. Best practice updates for informed consent and patient education in weight loss surgery. Obesity (Silver Spring) 2009; 17:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubino F, Nathan DM, Eckel RH, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Surg Obes Relat Dis 2016; 12:1144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aminian A, Chang J, Brethauer SA, et al. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis 2018; 14:1071.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsu WC, Araneta MR, Kanaya AM, et al. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care 2015; 38:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hutcheon DA, Ewing JA, St Ville M, et al. Insurance-mandated weight management program completion before bariatric surgery provides no long-term clinical benefit. Surg Obes Relat Dis 2023; 19:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JJ, Rogers AM, Ballem N, et al. ASMBS updated position statement on insurance mandated preoperative weight loss requirements. Surg Obes Relat Dis 2016; 12:955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic &amp; Bariatric Surgery. Obesity (Silver Spring) 2013; 21 Suppl 1:S1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yermilov I, McGory ML, Shekelle PW, et al. Appropriateness criteria for bariatric surgery: beyond the NIH guidelines. Obesity (Silver Spring) 2009; 17:1521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iranmanesh P, Boudreau V, Ramji K, et al. Outcomes of bariatric surgery in elderly patients: a registry-based cohort study with 3-year follow-up. Int J Obes (Lond) 2022; 46:574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong SC, Bolling CF, Michalsky MP, et al. Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices. Pediatrics 2019; 144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis 2018; 14:882.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter J, Chang J, Birriel TJ, et al. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis 2021; 17:1956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spirou D, Raman J, Smith E. Psychological outcomes following surgical and endoscopic bariatric procedures: A systematic review. Obes Rev 2020; 21:e12998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pearl RL, Allison KC, Shaw Tronieri J, Wadden TA. Reconsidering the Psychosocial-Behavioral Evaluation Required Prior to Bariatric Surgery. Obesity (Silver Spring) 2018; 26:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic &amp; Bariatric Surgery. Surg Obes Relat Dis 2013; 9:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JJ. Evidence Base for Optimal Preoperative Preparation for Bariatric Surgery: Does Mandatory Weight Loss Make a Difference? Curr Obes Rep 2017; 6:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gerber P, Anderin C, Thorell A. Weight loss prior to bariatric surgery: an updated review of the literature. Scand J Surg 2015; 104:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horwitz D, Saunders JK, Ude-Welcome A, Parikh M. Insurance-mandated medical weight management before bariatric surgery. Surg Obes Relat Dis 2016; 12:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heymsfield SB, Thomas DM, Bosy-Westphal A, Müller MJ. The anatomy of resting energy expenditure: body composition mechanisms. Eur J Clin Nutr 2019; 73:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. Surg Obes Relat Dis 2017; 13:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aminian A, Al-Kurd A, Wilson R, et al. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. JAMA 2021; 326:2031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazzini GS, Augustin T, Noria S, et al. ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis. Surg Obes Relat Dis 2022; 18:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Underwood P, Askari R, Hurwitz S, et al. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care 2014; 37:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meister KM, Hufford T, Tu C, et al. Clinical significance of perioperative hyperglycemia in bariatric surgery: evidence for better perioperative glucose management. Surg Obes Relat Dis 2018; 14:1725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Basishvili G, Yang J, Nie L, et al. HbA1C is not directly associated with complications of bariatric surgery. Surg Obes Relat Dis 2021; 17:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jellinger PS, Handelsman Y, Rosenblit PD, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com. Endocr Pract 2017; 23:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Raaff CAL, Gorter-Stam MAW, de Vries N, et al. Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline. Surg Obes Relat Dis 2017; 13:1095.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albaugh VL, Kindel TL, Nissen SE, Aminian A. Cardiovascular Risk Reduction Following Metabolic and Bariatric Surgery. Surg Clin North Am 2021; 101:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghiassi S, El Chaar M, Aleassa EM, et al. ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgery. Surg Obes Relat Dis 2020; 16:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haskins IN, Amdur R, Vaziri K. The effect of smoking on bariatric surgical outcomes. Surg Endosc 2014; 28:3074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chow A, Neville A, Kolozsvari N. Smoking in bariatric surgery: a systematic review. Surg Endosc 2021; 35:3047.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2014; :CD002294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           King WC, White GE, Belle SH, et al. Changes in Smoking Behavior Before and After Gastric Bypass: A 7-year Study. Ann Surg 2022; 275:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Athanasiadis DI, Christodoulides A, Monfared S, et al. High Rates of Nicotine Use Relapse and Ulcer Development Following Roux-en-Y Gastric Bypass. Obes Surg 2021; 31:640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stenberg E, Dos Reis Falcão LF, O'Kane M, et al. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg 2022; 46:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parikh M, Johnson JM, Ballem N, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS position statement on alcohol use before and after bariatric surgery. Surg Obes Relat Dis 2016; 12:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmed S, Pouwels S, Parmar C, et al. Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review. Obes Surg 2021; 31:2255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cerón-Solano G, Zepeda RC, Romero Lozano JG, et al. Bariatric surgery and alcohol and substance abuse disorder: A systematic review. Cir Esp (Engl Ed) 2021; 99:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007; 139:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004; 292:1573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shawe J, Ceulemans D, Akhter Z, et al. Pregnancy after bariatric surgery: Consensus recommendations for periconception, antenatal and postnatal care. Obes Rev 2019; 20:1507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mechanick JI, Apovian C, Brethauer S, et al. CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC &amp; BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY. Endocr Pract 2019; 25:1346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones DB, Abu-Nuwar MRA, Ku CM, et al. Less pain and earlier discharge after implementation of a multidisciplinary enhanced recovery after surgery (ERAS) protocol for laparoscopic sleeve gastrectomy. Surg Endosc 2020; 34:5574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grieco A, Huffman KM, Cohen ME, et al. The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program bariatric surgical risk/benefit calculator: 30-day risk. Surg Obes Relat Dis 2021; 17:1117.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 586 Version 41.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9813653" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11234459" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Obesity: preventing and managing the global epidemic. Report of a WHO consultation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11234459" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Obesity: preventing and managing the global epidemic. Report of a WHO consultation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24570244" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Prevalence of childhood and adult obesity in the United States, 2011-2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12513041" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Obesity in adulthood and its consequences for life expectancy: a life-table analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19190318" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Obesity and the economy: from crisis to opportunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17015201" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The impact of morbid obesity on the state economy: an initial evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22094013" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The medical care costs of obesity: an instrumental variables approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14656833" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Obesity costs UK economy 2bn pounds sterling a year.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17536599" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25562267" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Association between bariatric surgery and long-term survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25562267" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Association between bariatric surgery and long-term survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23338049" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Metabolic/bariatric surgery worldwide 2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28405878" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28405878" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1952493" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28196240" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36280539" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21245741" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20485136" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21438991" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Bariatric surgery: a systematic review and network meta-analysis of randomized trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19655209" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20811958" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Weight loss outcome after silastic ring Roux-en-Y gastric bypass: 8 years of follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19656740" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : International multicenter study of safety and effectiveness of Swedish Adjustable Gastric Band in 1-, 3-, and 5-year follow-up cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19272486" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20798226" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22449319" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22449317" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Bariatric surgery versus conventional medical therapy for type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21078684" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16670131" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19263156" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17015204" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Laparoscopic adjustable gastric banding for patients with body mass index of&lt;or=35 kg/m2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18212316" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21339423" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17940829" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI&gt;35 and&lt;35 kg/m2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22723580" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20185374" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20333558" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Metabolic surgery for the treatment of type 2 diabetes in patients with BMI&lt;35 kg/m2: an integrative review of early studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21499957" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Diabetes remission and insulin secretion after gastric bypass in patients with body mass index&lt;35 kg/m2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20739857" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20004451" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19475464" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18987919" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI&lt;30 kg/m2 (LBMI).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22051116" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index&lt;35 kg/m2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21479764" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19846351" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index&lt;35 kg/m(2).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19396067" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Best practice updates for informed consent and patient education in weight loss surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27568469" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30061070" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m2).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25538311" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36424327" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Insurance-mandated weight management program completion before bariatric surgery provides no long-term clinical benefit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27523728" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : ASMBS updated position statement on insurance mandated preoperative weight loss requirements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23529939" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic&amp;Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19343019" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Appropriateness criteria for bariatric surgery: beyond the NIH guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34837011" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Outcomes of bariatric surgery in elderly patients: a registry-based cohort study with 3-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31656225" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30077361" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34629296" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31994311" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Psychological outcomes following surgical and endoscopic bariatric procedures: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29282873" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Reconsidering the Psychosocial-Behavioral Evaluation Required Prior to Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23537696" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic&amp;Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28755179" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Evidence Base for Optimal Preoperative Preparation for Bariatric Surgery: Does Mandatory Weight Loss Make a Difference?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25388885" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Weight loss prior to bariatric surgery: an updated review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26775043" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Insurance-mandated medical weight management before bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30254244" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The anatomy of resting energy expenditure: body composition mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28392254" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34762106" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34953742" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24170760" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30245036" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Clinical significance of perioperative hyperglycemia in bariatric surgery: evidence for better perioperative glucose management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33243668" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : HbA1C is not directly associated with complications of bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28156151" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28666588" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33743969" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Cardiovascular Risk Reduction Following Metabolic and Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32359998" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24902816" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : The effect of smoking on bariatric surgical outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32524412" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Smoking in bariatric surgery: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24671929" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Interventions for preoperative smoking cessation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32084036" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Changes in Smoking Behavior Before and After Gastric Bypass: A 7-year Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32959330" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : High Rates of Nicotine Use Relapse and Ulcer Development Following Roux-en-Y Gastric Bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34984504" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26968500" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : ASMBS position statement on alcohol use before and after bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33595790" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34690075" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Bariatric surgery and alcohol and substance abuse disorder: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17897305" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15467059" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Estrogen plus progestin and risk of venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31419378" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Pregnancy after bariatric surgery: Consensus recommendations for periconception, antenatal and postnatal care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31682518" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC&amp;BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31938928" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Less pain and earlier discharge after implementation of a multidisciplinary enhanced recovery after surgery (ERAS) protocol for laparoscopic sleeve gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33773930" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program bariatric surgical risk/benefit calculator: 30-day risk.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
